Thor Medical ASA

Oslo Stock Exchange TRMED.OL

Thor Medical ASA Capital Expenditure for the year ending December 31, 2023: USD 0.00

Thor Medical ASA Capital Expenditure is USD 0.00 for the year ending December 31, 2023, a 100.00% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Thor Medical ASA Capital Expenditure for the year ending December 31, 2022 was USD -573.77 K, a -1,855.98% change year over year.
  • Thor Medical ASA Capital Expenditure for the year ending December 31, 2021 was USD -29.33 K, a -36.06% change year over year.
  • Thor Medical ASA Capital Expenditure for the year ending December 31, 2020 was USD -21.56 K.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Oslo Stock Exchange: TRMED.OL

Thor Medical ASA

CEO Mr. Jasper Kurth
IPO Date March 23, 2015
Location Norway
Headquarters Karenslyst allé 9C
Employees 5
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.

StockViz Staff

January 15, 2025

Any question? Send us an email